{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:41:58Z","timestamp":1740123718085,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"publisher","award":["Linea D1"],"award-info":[{"award-number":["Linea D1"]}],"id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s10689-019-00139-3","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T06:49:23Z","timestamp":1562741363000},"page":"421-427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lynch syndrome with exclusive skin involvement: time to consider a molecular definition?"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8413-621X","authenticated-orcid":false,"given":"Alessandro","family":"Vaisfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-5809","authenticated-orcid":false,"given":"Martina","family":"Calicchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0417-9939","authenticated-orcid":false,"given":"Maria Grazia","family":"Pomponi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-7604","authenticated-orcid":false,"given":"Emanuela","family":"Lucci-Cordisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9917-4080","authenticated-orcid":false,"given":"Luca","family":"Reggiani-Bonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-8351","authenticated-orcid":false,"given":"Maurizio","family":"Genuardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"139_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/bjs.1800540309","volume":"54","author":"EG Muir","year":"1967","unstructured":"Muir EG, Bell AJ, Barlow KA (1967) Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthomata of the face. Br J Surg 54:191\u2013195","journal-title":"Br J Surg"},{"key":"139_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1001\/archderm.98.5.549","volume":"98","author":"D Torre","year":"1968","unstructured":"Torre D (1968) Multiple sebaceous tumors. Arch Dermatol 98:549\u2013551","journal-title":"Arch Dermatol"},{"issue":"2","key":"139_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/bjd.16552","volume":"179","author":"F Adan","year":"2018","unstructured":"Adan F, Crijns MB, Zandstra WSE, Bekkenk MW, Bleeker FE, Dekker E, van Leerdam ME (2018) Cumulative risk of skin tumours in patients with Lynch syndrome. Br J Dermatol 179(2):522\u2013523. \n                    https:\/\/doi.org\/10.1111\/bjd.16552","journal-title":"Br J Dermatol"},{"key":"139_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0190-9622(99)70001-0","volume":"41","author":"S Akhtar","year":"1999","unstructured":"Akhtar S, Oza KK, Khan SA, Wright J (1999) Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol 41:681\u2013686","journal-title":"J Am Acad Dermatol"},{"key":"139_CR5","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.5858\/arpa.2013-0301-RS","volume":"138","author":"F Bhaijee","year":"2014","unstructured":"Bhaijee F, Brown AS (2014) Muir-Torre syndrome. Arch Pathol Lab Med 138:1685\u20131689. \n                    https:\/\/doi.org\/10.5858\/arpa.2013-0301-RS","journal-title":"Arch Pathol Lab Med"},{"key":"139_CR6","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/0002-9343(91)90637-D","volume":"90","author":"PR Cohen","year":"1991","unstructured":"Cohen PR, Kohn SR, Kurzrock R (1991) Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 90:606\u2013613","journal-title":"Am J Med"},{"key":"139_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S1470-2045(05)70465-4","volume":"6","author":"G Ponti","year":"2005","unstructured":"Ponti G, Ponz de Leon M (2005) Muir-Torre syndrome. Lancet Oncol 6:980\u2013987. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(05)70465-4","journal-title":"Lancet Oncol"},{"key":"139_CR8","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jaad.2015.09.074","volume":"74","author":"AM John","year":"2016","unstructured":"John AM, Schwartz RA (2016) Muir-Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol 74:558\u2013566. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2015.09.074","journal-title":"J Am Acad Dermatol"},{"key":"139_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/jnci\/djm291","volume":"100","author":"CD South","year":"2008","unstructured":"South CD, Hampel H, Comeras I, Westman JA, Frankel WL, de la Chapelle A (2008) The frequency of Muir-Torre syndrome among Lynch Syndrome families. J Natl Cancer Inst 100:277\u2013281. \n                    https:\/\/doi.org\/10.1093\/jnci\/djm291","journal-title":"J Natl Cancer Inst"},{"key":"139_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/ced.13359","volume":"43","author":"K Schon","year":"2018","unstructured":"Schon K, Ritina E, Drummond J, Simmonds J, Anns S, Sandford R, Tischkowitz M (2018) Evaluation of universal immunohistochemical screening of sebaceous neoplasms in a service setting. Clin Exp Dermatol 43:410\u2013415. \n                    https:\/\/doi.org\/10.1111\/ced.13359","journal-title":"Clin Exp Dermatol"},{"key":"139_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1086\/301926","volume":"63","author":"R Kruse","year":"1998","unstructured":"Kruse R, R\u00fctten A, Lamberti C, Hosseiny-Malayeri HR, Wang Y, Ruelfs C, Jungck M, Mathiak M, Ruzicka T, Hartschuh W, Bisceglia M, Friedl W, Propping P (1998) Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 63:63\u201370. \n                    https:\/\/doi.org\/10.1086\/301926","journal-title":"Am J Hum Genet"},{"key":"139_CR12","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"SE Plon","year":"2008","unstructured":"Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FB, Hoogerbrugge N, Spurdle AB, Tavtigian SV, IARC Unclassified Genetic Variants Working Group (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29:1282\u20131291. \n                    https:\/\/doi.org\/10.1002\/humu.20880","journal-title":"Hum Mutat"},{"key":"139_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1158\/1055-9965.EPI-13-1165","volume":"23","author":"S Ryan","year":"2014","unstructured":"Ryan S, Jenkins MA, Win AK (2014) Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev 23:437\u2013449. \n                    https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-1165","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"139_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12894-016-0130-1","volume":"16","author":"M Dominguez-Valentin","year":"2016","unstructured":"Dominguez-Valentin M, Joost P, Therkildsen C, Jonsson M, Rambech E, Nilbert M (2016) Frequent mismatch-repair defects link\u00a0prostate cancer to Lynch syndrome. BMC Urol 16:15. \n                    https:\/\/doi.org\/10.1186\/s12894-016-0130-1","journal-title":"BMC Urol"},{"key":"139_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/gim.2013.193","volume":"16","author":"S Haraldsdottir","year":"2014","unstructured":"Haraldsdottir S, Hampel H, Wei L, Wu C, Frankel W, Bekaii-Saab T, de la Chapelle A, Goldberg RM (2014) Prostate cancer incidence in males with Lynch syndrome. Genet Med 16:553\u2013557. \n                    https:\/\/doi.org\/10.1038\/gim.2013.193","journal-title":"Genet Med"},{"key":"139_CR16","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","volume":"30","author":"C Engel","year":"2012","unstructured":"Engel C, Loeffler M, Steinke V, Rahner N, Holinski-Feder E, Dietmaier W, Schackert HK, Goergens H, von Knebel Doeberitz M, Goecke TO, Schmiegel W, Buettner R, Moeslein G, Letteboer TG, G\u00f3mez Garc\u00eda E, Hes FJ, Hoogerbrugge N, Menko FH, van Os TA, Sijmons RH, Wagner A, Kluijt I, Propping P, Vasen HF (2012) Risks of less common cancers in proven mutation carriers with Lynch syndrome. J Clin Oncol 30:4409\u20134415. \n                    https:\/\/doi.org\/10.1200\/JCO.2012.43.2278","journal-title":"J Clin Oncol"},{"key":"139_CR17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","volume":"62","author":"HFA Vasen","year":"2013","unstructured":"Vasen HFA, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, Bernstein I, Bertario L, Burn J, Capella G, Colas C, Engel C, Frayling IM, Genuardi M, Heinimann K, Hes FJ, Hodgson SV, Karagiannis JA, Lalloo F, Lindblom A, Mecklin JP, M\u00f8ller P, Myrhoj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Sijmons RH, Tejpar S, Thomas HJW, Rahner N, Wijnen JT, J\u00e4rvinen HJ, M\u00f6slein G, the Mallorca Group (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62:812\u2013823. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2012-304356","journal-title":"Gut"},{"key":"139_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/ng.2854","volume":"46","author":"BA Thompson","year":"2014","unstructured":"Thompson BA, Spurdle AB, Plazzer JP, Greenblatt MS, Akagi K, Al-Mulla F, Bapat B, Bernstein I, Capell\u00e1 G, den Dunnen JT, du Sart D, Fabre A, Farrell MP, Farrington SM, Frayling IM, Frebourg T, Goldgar DE, Heinen CD, Holinski-Feder E, Kohonen-Corish M, Robinson KL, Leung SY, Martins A, Moller P, Morak M, Nystrom M, Peltomaki P, Pineda M, Qi M, Ramesar R, Rasmussen LJ, Royer-Pokora B, Scott RJ, Sijmons R, Tavtigian SV, Tops CM, Weber T, Wijnen J, Woods MO, Macrae F, Genuardi M (2014) Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet 46:107\u2013115. \n                    https:\/\/doi.org\/10.1038\/ng.2854","journal-title":"Nat Genet"},{"key":"139_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/humu.22213","volume":"34","author":"BA Thompson","year":"2013","unstructured":"Thompson BA, Goldgar DE, Paterson C, Clendenning M, Walters R, Arnold S, Parsons MT, Michael DW, Gallinger S, Haile RW, Hopper JL, Jenkins MA, Lemarchand L, Lindor NM, Newcomb PA, Thibodeau SN, Registry Colon Cancer Family, Young JP, Buchanan DD, Tavtigian SV, Spurdle AB (2013) A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry. Hum Mutat 34:200\u2013209. \n                    https:\/\/doi.org\/10.1002\/humu.22213","journal-title":"Hum Mutat"},{"key":"139_CR20","doi-asserted-by":"publisher","first-page":"711716","DOI":"10.1038\/gim.2014.19","volume":"16","author":"ME Roberts","year":"2014","unstructured":"Roberts ME, Riegert-Johnson DL, Thomas BC, Rumilla KM, Thomas CS, Heckman MG, Purcell JU, Krishna M, Hanson NB, Leppig KA, Lim J, Cappel MA (2014) A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Genet Med 16:711716. \n                    https:\/\/doi.org\/10.1038\/gim.2014.19","journal-title":"Genet Med"},{"key":"139_CR21","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1038\/sj.jid.5700475","volume":"126","author":"G Ponti","year":"2006","unstructured":"Ponti G, Losi L, Pedroni M, Lucci-Cordisco E, Di Gregorio C, Pellacani G, Seidenari S (2006) Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. J Invest Dermatol 126:2302\u20132307. \n                    https:\/\/doi.org\/10.1038\/sj.jid.5700475","journal-title":"J Invest Dermatol"},{"key":"139_CR22","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamadermatol.2014.1217","volume":"150","author":"MM Everett","year":"2014","unstructured":"Everett MM, Raymond VM, Dandapani M, Marvin M, Kohlmann W, Chittenden A, Koeppe E, Gustafson SL, Else T, Fullen DR, Johnon RM, Syngal S, Gruber SB, Stoffel E (2014) Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasms. JAMA Dermatol 150:1315\u20131321. \n                    https:\/\/doi.org\/10.1001\/jamadermatol.2014.1217","journal-title":"JAMA Dermatol"},{"key":"139_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10689-015-9782-3","volume":"14","author":"AR Lamba","year":"2015","unstructured":"Lamba AR, Moore AY, Moore T, Rhees J, Arnold MA, Boland CR (2015) Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome. Fam Cancer 14:259\u2013264. \n                    https:\/\/doi.org\/10.1007\/s10689-015-9782-3","journal-title":"Fam Cancer"},{"key":"139_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2015.10.005","volume":"49","author":"CJ Jessup","year":"2016","unstructured":"Jessup CJ, Redton M, Tilton E, Reimann JDR (2016) Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome. Hum Pathol 49:1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2015.10.005","journal-title":"Hum Pathol"},{"key":"139_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.gene.2015.06.078","volume":"589","author":"G Ponti","year":"2015","unstructured":"Ponti G, Manfredini M, Tomasi A, Pellacani G (2015) Muir-Torre syndrome and founder mismatch repair gene mutations: a long gone historical genetic challenge. Gene 589:127\u2013132. \n                    https:\/\/doi.org\/10.1016\/j.gene.2015.06.078","journal-title":"Gene"},{"key":"139_CR26","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1053\/j.gastro.2006.08.044","volume":"131","author":"S Ollila","year":"2006","unstructured":"Ollila S, Sarantaus L, Kariola R, Chan P, Hampel H, Holinski-Feder E, Macrae F, Kohonen-Corish M, Gerdes AM, Peltom\u00e4ki P, Mangold E, de la Chapelle A, Greenblatt M, Nystr\u00f6m M (2006) Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein. Gastroenterology 131:1408\u20131417. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2006.08.044","journal-title":"Gastroenterology"},{"key":"139_CR27","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/archopht.116.12.1670","volume":"116","author":"S Rumelt","year":"1998","unstructured":"Rumelt S, Hogan NR, Rubin PA, Jakobiec FA (1998) Four-eyelid sebaceous cell carcinoma following irradiation. Arch Ophthalmol 116:1670\u20131672","journal-title":"Arch Ophthalmol"},{"key":"139_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/00000372-198612000-00009","volume":"8","author":"IC Hood","year":"1986","unstructured":"Hood IC, Qizilbash AH, Salama SS, Young JE, Archibald SD (1986) Sebaceous carcinoma of the face following irradiation. Am J Dermatopathol 8:505\u2013508","journal-title":"Am J Dermatopathol"},{"key":"139_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/QAD.0b013e3283213046","volume":"23","author":"E Lanoy","year":"2009","unstructured":"Lanoy E, Dores GM, Madeleine MM, Toro JR, Fraumeni JF Jr, Engels EA (2009) Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS 23:385\u2013393. \n                    https:\/\/doi.org\/10.1097\/QAD.0b013e3283213046","journal-title":"AIDS"},{"key":"139_CR30","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jaad.2010.08.003","volume":"65","author":"MN Landis","year":"2011","unstructured":"Landis MN, Davis CL, Bellus GA, Wolverton SE (2011) Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy. J Am Acad Dermatol 65:1054\u20131058. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2010.08.003","journal-title":"J Am Acad Dermatol"},{"key":"139_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1067\/mjd.2003.97","volume":"48","author":"CA Harwood","year":"2003","unstructured":"Harwood CA, McGregor JM, Swale VJ, Proby CM, Leigh IM, Newton R, Khorshid SM, Cerio R (2003) High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J Am Acad Dermatol 48:401\u2013408. \n                    https:\/\/doi.org\/10.1067\/mjd.2003.97","journal-title":"J Am Acad Dermatol"},{"key":"139_CR32","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41467-018-04008-y","volume":"14","author":"JP North","year":"2018","unstructured":"North JP, Golovato J, Vaske CJ, Sanborn JZ, Nuyen A, Wu W, Goode B, Stevers M, McMullen K, Perez White BE, Collisson EA, Bloomer M, Solomon DA, Benz SC, Cho RJ (2018) Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma. Nat Commun 14:1894. \n                    https:\/\/doi.org\/10.1038\/s41467-018-04008-y","journal-title":"Nat Commun"},{"key":"139_CR33","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1200\/JCO.1997.15.7.2744","volume":"15","author":"F Paraf","year":"1997","unstructured":"Paraf F, Jothy S, Van Meir EG (1997) Brain tumor-polyposis syndrome: two genetic diseases? J Clin Oncol 15:2744\u20132758","journal-title":"J Clin Oncol"},{"key":"139_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/archinte.1981.00340050059016","volume":"141","author":"HT Lynch","year":"1981","unstructured":"Lynch HT, Lynch PM, Pester J, Fusaro RM (1981) The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre\u2019s syndrome. Arch Intern Med 141:607\u2013611","journal-title":"Arch Intern Med"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-019-00139-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-019-00139-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-019-00139-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T23:17:08Z","timestamp":1594250228000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-019-00139-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["139"],"URL":"https:\/\/doi.org\/10.1007\/s10689-019-00139-3","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2019,7,10]]},"assertion":[{"value":"10 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Informed consent for genetic testing was obtained from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}